Hypha Labs, Inc.
FUNI · Services-Testing Laboratories · 163.9M shares · +17%/yr ↑ shares · EDGAR filings ↗
Grade
D46gen composite 50pct→67; negative equity (distress); weak liquidity, no op profit
Notable findings
- Auditor changeRecent 8-K item 4.01 8-K ↗
- Cash burnNegative free cash flow (-0.4M)
- Chronic dilutionShare count +17%/yr over 2y (dilution)
- Negative equityNegative book equity (debt/equity -0.54)
- Weak liquidityCurrent ratio 0.13 (<1)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
127.3%
Return on assets
-758.0%
Revenue growth (QoQ)
3.9%
Debt / equity
-0.5×
Current ratio
0.1×
Free cash flow
-$413K
Tangible book value
-$2M
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-01-30 | Auditor changeExhibits | filing ↗ |
| 2025-01-24 | Material agreementExec/director change5.05Exhibits | filing ↗ |
| 2025-01-16 | 5.03Exhibits | filing ↗ |
| 2024-12-16 | Material agreement3.02Shareholder voteExhibits | filing ↗ |
| 2024-04-15 | 5.03Exhibits | filing ↗ |
| 2024-03-01 | Exec/director changeExhibits | filing ↗ |
| 2024-02-23 | Acquisition/dispositionExhibits | filing ↗ |
| 2023-10-03 | Auditor changeExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-05-15 | 2026-03-31 | 0001493152-26-023548 ↗ |
| 10-Q | 2026-02-17 | 2025-12-31 | 0001493152-26-007109 ↗ |
| 8-K | 2026-01-30 | 2026-01-27 | 0001493152-26-004370 ↗ |
| 10-K | 2026-01-15 | 2025-09-30 | 0001493152-26-002451 ↗ |
| 10-Q | 2025-08-21 | 2025-06-30 | 0001641172-25-025082 ↗ |
| 10-Q | 2025-06-13 | 2025-03-31 | 0001641172-25-015098 ↗ |
| 10-Q | 2025-02-14 | 2024-12-31 | 0001493152-25-006922 ↗ |
| 8-K | 2025-01-24 | 2025-01-21 | 0001493152-25-003647 ↗ |
| 8-K | 2025-01-16 | 2025-01-15 | 0001493152-25-002568 ↗ |
| 10-K | 2025-01-13 | 2024-09-30 | 0001493152-25-001966 ↗ |
| 8-K | 2024-12-16 | 2024-12-10 | 0001493152-24-050186 ↗ |
| 10-Q | 2024-08-14 | 2024-06-30 | 0001493152-24-032361 ↗ |